Back to top

Image: Bigstock

MediWound (MDWD) Jumps: Stock Rises 9.4%

Read MoreHide Full Article

MediWound Ltd. (MDWD - Free Report) was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 100.5% in the past one-month time frame.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

MediWound currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

MediWound Ltd. Price

Investors interested in the Medical - Drugs industry may consider Neurocrine Biosciences Inc (NBIX - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Neurocrine Biosciences, Inc. (NBIX) - free report >>

MediWound Ltd. (MDWD) - free report >>

Published in